UNSPSC 51451901: Bromoxanide

This classification denotes an antihelminthic agent with the molecular formula C19H18BrF3N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9MM438AA0G, chemically known as 4-bromo-3-tert-butyl-alpha,alpha,alpha-trifluoro-5-nitro-2,6-cresoto-o-toluidide but generally known as bromoxanide, which bears US NIH Compound Identifier 166570. European Medicines Agency schedules Bromoxanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05922MIG.

UNSPSC 51451901 Bromoxanide, a Commodity code, does not align with the state and local procurement activity currently tagged under it. Recent opportunities recorded under this code involve naloxone and drug-deactivation systems procurement, therapeutic pharmacy initiatives, emergency medical supplies, and generic pharmaceutical contracting — none of which concern bromoxanide, an industrial chemical compound unrelated to the health and pharmacy products actually being solicited. The code shows a systematic mismatch between its nominal scope and the work state and local buyers are executing.

The issuing bodies pursuing opportunities tagged to this code span health departments, county public-health agencies, city fire departments, and multi-state cooperative purchasing alliances. Seminole County, Florida is procuring naloxone and safe-drug deactivation systems through an IFB due July 26, 2023; the City of Tampa's Fire Department Rescue Division is bidding medical and first aid supplies (estimated contract value $700,000.00) via ITB closing March 13, 2026 with a sheltered small local business enterprise (SLBE) set-aside; the Texas Health and Human Services Commission issued an RFI in April 2026 to explore direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administers a statewide RFP for generic multi-source pharmaceuticals and over-the-counter products closing March 26, 2026, effective July 1, 2026. Geographic activity centers on Florida, Texas, and Minnesota, with MMCAP extending to Oregon. Because the code's nominal product bears no relation to the actual procurement activity assigned to it, this code warrants a review of its assignment accuracy before business development professionals pursue opportunities under its label.